<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">PSEUDOEPHEDRINE HYDROCHLORIDE</span><br/>(soo-doe-e-fed'rin)<br/><span class="topboxtradename">Cenafed, </span><span class="topboxtradename">Decongestant Syrup, </span><span class="topboxtradename">Dorcol Children's Decongestant, </span><span class="topboxtradename">Eltor <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Eltor 120 <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Halofed, </span><span class="topboxtradename">Novafed, </span><span class="topboxtradename">PediaCare, </span><span class="topboxtradename">Pseudofrin <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Robidrine <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Sudafed, </span><span class="topboxtradename">Sudrin<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">alpha- and beta-adrenergic agonist (sympathomimetic)</span>; <span class="classification">decongestant</span><br/><b>Prototype: </b>Epinephrine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>30 mg, 60 mg tablets; 120 mg, 240 mg sustained release tablets; 15 mg/5 mL, 30 mg/5 mL liquid; 7.5 mg/0.8 mL drops</p>
<h1><a name="action">Actions</a></h1>
<p>Sympathomimetic amine that, like ephedrine, produces decongestion of respiratory tract mucosa by stimulating the sympathetic
         nerve endings including alpha-, beta-1 and beta-2 receptors. Unlike ephedrine, also acts directly on smooth muscle and constricts
         renal and vertebral arteries. Has fewer adverse effects, less pressor action, and longer duration of effects than ephedrine.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Effective as a nasal decongestant.</p>
<h1><a name="uses">Uses</a></h1>
<p>Symptomatic relief of nasal congestion associated with rhinitis, coryza, and sinusitis and for eustachian tube congestion.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to sympathomimetic amines; severe hypertension; coronary artery disease; use within 14 d of <small>MAOI</small>s; glaucoma; hyperthyroidism; prostatic hypertrophy. Safety during pregnancy (category C), lactation, or in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Hypertension, heart disease.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Nasal Congestion</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 60 mg q46h or 120 mg sustained release q12h<br/><span class="rdage">Geriatric:</span> <span class="rdroute">PO</span> 3060 mg q6h prn<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> <i>26 y,</i> 15 mg q46h (max: 60 mg/d); <i>611 y,</i> 30 mg q46h (max: 120 mg/d)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Ensure that sustained release form is not chewed or crushed. Must be swallowed whole.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> <span class="speceff-common">Transient stimulation,</span> tremulousness, difficulty in voiding. <span class="typehead">CV:</span> Arrhythmias, palpitation, <span class="speceff-common">tachycardia.</span> <span class="typehead">CNS:</span> <span class="speceff-common">Nervousness,</span> dizziness, headache, sleeplessness, numbness of extremities. <span class="typehead"> GI:</span>  Anorexia, dry mouth, nausea, vomiting. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> Other <span class="classification">sympathomimetics</span> increase pressor effects and toxicity; <span class="classification">mao inhibitors</span> may precipitate hypertensive crisis; <span class="classification">beta blockers</span> may increase pressor effects; may decrease antihypertensive effects of <b>guanethidine,</b> <b>methyldopa,</b> <b>reserpine.</b>
<h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 1530 min. <span class="typehead">Duration:</span> 46 h (812 h sustained release). <span class="typehead">Distribution:</span> Crosses placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Partially metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor HR and BP, especially in those with a history of cardiac disease. Report tachycardia or hypertension.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Avoid taking it within 2 h of bedtime because drug may act as a stimulant.</li>
<li>Discontinue medication and consult physician if extreme restlessness or signs of sensitivity occur.</li>
<li>Consult physician before concomitant use of OTC medications; many contain ephedrine or other sympathomimetic amines and might
            intensify action of pseudoephedrine.
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>